AVKARE Inc. FDA Record
- Latest inspection VAI · Nov 2, 2022
- 2 Class I recalls
- No warning letters matched by name
AVKARE Inc. has 62 FDA recalls (2 Class I), 4 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "AVKARE Inc." is on file.
- Latest recall
- D-0341-2026 · Class II · Feb 13, 2026
- Latest inspection
- Nov 2, 2022 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 62 (2 Class I) | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 4 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
AVKARE Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 1 | 0 |
| 2025 | 0 | 0 | 0 | 10 | 0 |
| 2024 | 0 | 0 | 0 | 9 | 1 |
| 2023 | 0 | 0 | 0 | 3 | 0 |
| 2022 | 2 | 0 | 0 | 2 | 0 |
| 2021 | 0 | 0 | 0 | 1 | 0 |
| 2020 | 0 | 0 | 0 | 7 | 1 |
| 2019 | 0 | 0 | 0 | 12 | 0 |
| 2018 | 0 | 0 | 0 | 12 | 0 |
| 2017 | 1 | 0 | 0 | 3 | 0 |
Reviewing AVKARE Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check AVKARE Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0341-2026 | Class II | Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for… | Feb 13, 2026 |
| D-0292-2026 | Class II | Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured… | Dec 31, 2025 |
| D-0007-2026 | Class II | Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25… | Sep 2, 2025 |
| D-0644-2025 | Class II | chloroproMAZINE Hydrochloride Tablets, USP, 100 mg, 50 Tablets (5x10) unit dose carton, Rx only… | Aug 25, 2025 |
| D-0643-2025 | Class II | chloroproMAZINE Hydrochloride Tablets, USP, 50 mg, 50 Tablets (5x10) unit dose carton, Rx only… | Aug 25, 2025 |
| D-0528-2025 | Class III | Pitavastatin Tablets, 1 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, Pulaski, TN… | Jun 26, 2025 |
| D-0529-2025 | Class III | Pitavastatin Tablets, 2 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, Pulaski, TN… | Jun 26, 2025 |
| D-0460-2025 | Class II | Celecoxib Capsules, 200 mg, 50 Capsules (5x10) Unit Dose per carton, Rx Only, Manufactured for… | May 13, 2025 |
| D-0461-2025 | Class II | Chlorthalidone Tablets, USP, 25 mg, 50 Tablets (5x10) Unit Dose cards per carton, Rx only… | May 9, 2025 |
| D-0229-2025 | Class II | Silodosin Capsules, 8mg, 90-count bottle, Rx only, Manufactured for: AvKare, Pulaski, TN 38478… | Feb 4, 2025 |
| D-0224-2025 | Class II | Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE… | Jan 21, 2025 |
| D-0176-2025 | Class III | Polyvinyl Alcohol Ophthalmic Solution 1.4%, Moisturizing Lubricant Eye Drops, 0.5 FL OZ (15 mL)… | Dec 18, 2024 |
| D-0175-2025 | Class III | Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% Moisturizing Lubricant Eye Drops, 0.5 FL OZ… | Dec 18, 2024 |
| D-0168-2025 | Class II | Nitrofurantoin Capsules, USP, 100 mg, 50 Capsules (5 x 10) Unit Dose per carton, Rx Only… | Dec 4, 2024 |
| D-0110-2025 | Class II | Cinacalcet Tablets, 90 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478… | Nov 27, 2024 |
| D-0108-2025 | Class II | Cinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478… | Nov 27, 2024 |
| D-0109-2025 | Class II | Cinacalcet Tablets, 60 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478… | Nov 27, 2024 |
| D-0104-2025 | Class II | Sunitinib Malate Capsules, 25 mg, 28-count bottles, Rx Only, Manufactured for: AvKARE, Pulaski, TN… | Oct 18, 2024 |
| D-0103-2025 | Class II | Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx Only, Manufactured for: AvKARE, Pulaski, TN… | Oct 18, 2024 |
| D-0444-2024 | Class I | Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx Only… | Mar 28, 2024 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Nov 2, 2022 | Pulaski, TN | Drugs | Voluntary Action Indicated (VAI) | 3007255004 |
| Aug 23, 2022 | Pulaski, TN | Drugs | No Action Indicated (NAI) | 3007255004 |
| Jun 6, 2017 | Pulaski, TN | Drugs | No Action Indicated (NAI) | 3007255004 |
| Jun 9, 2014 | Pulaski, TN | Drugs | No Action Indicated (NAI) | 3007255004 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3007255004 | Pulaski, TN | 4 | Nov 2, 2022 |
AVKARE Inc. and the FDA: common questions
Has AVKARE Inc. received an FDA warning letter?
No FDA warning letter addressed to the name "AVKARE Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has AVKARE Inc. received an FDA Form 483?
FDA has not published a Form 483 for "AVKARE Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect AVKARE Inc.?
The most recent FDA inspection on file ended Nov 2, 2022 at Pulaski, TN and was classified VAI. FDA has 4 inspections of AVKARE Inc. on file.
Has AVKARE Inc. had an FDA recall?
Yes. AVKARE Inc. has 62 FDA recalls on record, 2 of them Class I, the most serious class. The most recent started Feb 13, 2026.
Need more than this page shows? Ask about AVKARE Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.